Found: 54
Select item for more details and to access through your institution.
Characteristics of High-Titer Convalescent Plasma and Antibody Dynamics After Administration in Patients With Severe Coronavirus Disease 2019.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 8, p. 1, doi. 10.1093/ofid/ofab385
- By:
- Publication type:
- Article
Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Serologic Prevalence of Ebola Virus in Equatorial Africa.
- Published in:
- 2019
- By:
- Publication type:
- journal article
High Incidence of Chikungunya Virus and Frequency of Viremic Blood Donations during Epidemic, Puerto Rico, USA, 2014.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Detection of neutralizing antibodies against multiple SARS-CoV-2 strains in dried blood spots using cell-free PCR.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31796-1
- By:
- Publication type:
- Article
Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications.
- Published in:
- PLoS Neglected Tropical Diseases, 2020, v. 14, n. 11, p. 1, doi. 10.1371/journal.pntd.0008730
- By:
- Publication type:
- Article
Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes.
- Published in:
- 2005
- By:
- Publication type:
- journal article
A high-throughput screening assay to identify inhibitory antibodies targeting alphavirus release.
- Published in:
- Virology Journal, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12985-022-01906-y
- By:
- Publication type:
- Article
Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42836-9
- By:
- Publication type:
- Article
Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42836-9
- By:
- Publication type:
- Article
Human galectin-9 potently enhances SARS-CoV-2 replication and inflammation in airway epithelial cells.
- Published in:
- Journal of Molecular Cell Biology, 2023, v. 15, n. 4, p. 1, doi. 10.1093/jmcb/mjad030
- By:
- Publication type:
- Article
In-Depth Investigation of Archival and Prospectively Collected Samples Reveals No Evidence for XMRV Infection in Prostate Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0044954
- By:
- Publication type:
- Article
No Evidence of Murine Leukemia Virus-Related Viruses in Live Attenuated Human Vaccines.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0029223
- By:
- Publication type:
- Article
No Evidence for XMRV Nucleic Acids, Infectious Virus or Anti-XMRV Antibodies in Canadian Patients with Chronic Fatigue Syndrome.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0027870
- By:
- Publication type:
- Article
Duration of Dengue Viremia in Blood Donors and Relationships Between Donor Viremia, Infection Incidence and Clinical Case Reports During a Large Epidemic.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Interferon-Induced Transmembrane Protein-Mediated Inhibition of Host Cell Entry of Ebolaviruses.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 4, p. 1, doi. 10.1371/journal.ppat.1009925
- By:
- Publication type:
- Article
An attenuated replication-competent chikungunya virus with a fluorescently tagged envelope.
- Published in:
- PLoS Neglected Tropical Diseases, 2018, v. 12, n. 8, p. 1, doi. 10.1371/journal.pntd.0006693
- By:
- Publication type:
- Article
Human IFITM3 restricts chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction.
- Published in:
- Life Science Alliance, 2021, v. 4, n. 7, p. 1, doi. 10.26508/lsa.202000909
- By:
- Publication type:
- Article
Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands.
- Published in:
- Immunological Reviews, 2000, v. 177, n. 1, p. 112, doi. 10.1034/j.1600-065x.2000.17719.x
- By:
- Publication type:
- Article
Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-56551-3
- By:
- Publication type:
- Article
Comparative Evaluation of Select Serological Assays for Zika Virus Using Blinded Reference Panels.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 7, p. 1075, doi. 10.3390/v16071075
- By:
- Publication type:
- Article
Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 4, p. 305, doi. 10.3390/v11040305
- By:
- Publication type:
- Article
Establishment of an Alphavirus-Specific Neutralization Assay to Distinguish Infections with Different Members of the Semliki Forest Complex.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 1, p. 82, doi. 10.3390/v11010082
- By:
- Publication type:
- Article
Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 5, p. 871, doi. 10.1093/cid/ciab537
- By:
- Publication type:
- Article
Arbovirus Diagnostics: From Bad to Worse due to Expanding Dengue Virus Vaccination and Zika Virus Epidemics.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 8, p. 1181, doi. 10.1093/cid/cix972
- By:
- Publication type:
- Article
Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 11, p. 1829, doi. 10.1093/cid/cix672
- By:
- Publication type:
- Article
Correction: A Novel Rhabdovirus Associated with Acute Hemorrhagic Fever in Central Africa.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
A Novel Rhabdovirus Associated with Acute Hemorrhagic Fever in Central Africa.
- Published in:
- PLoS Pathogens, 2012, v. 8, n. 9, p. 1, doi. 10.1371/journal.ppat.1002924
- By:
- Publication type:
- Article
Distinct SARS-CoV-2 antibody reactivity patterns in coronavirus convalescent plasma revealed by a coronavirus antigen microarray.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-87137-7
- By:
- Publication type:
- Article
Zika Virus Tissue and Blood Compartmentalization in Acute Infection of Rhesus Macaques.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0171148
- By:
- Publication type:
- Article
Plasma transfusion–transmission of Zika virus in mice and macaques.
- Published in:
- Transfusion, 2023, v. 63, n. 3, p. 574, doi. 10.1111/trf.17243
- By:
- Publication type:
- Article
Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction.
- Published in:
- Transfusion, 2022, v. 62, n. 7, p. 1388, doi. 10.1111/trf.16950
- By:
- Publication type:
- Article
Vaccination of COVID‐19 convalescent plasma donors increases binding and neutralizing antibodies against SARS‐CoV‐2 variants.
- Published in:
- Transfusion, 2022, v. 62, n. 3, p. 563, doi. 10.1111/trf.16823
- By:
- Publication type:
- Article
Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment.
- Published in:
- Transfusion, 2022, v. 62, n. 3, p. 570, doi. 10.1111/trf.16819
- By:
- Publication type:
- Article
SARS‐CoV‐2 antibody persistence in COVID‐19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance.
- Published in:
- Transfusion, 2021, v. 61, n. 9, p. 2677, doi. 10.1111/trf.16555
- By:
- Publication type:
- Article
Selecting COVID-19 convalescent plasma for neutralizing antibody potency using a high-capacity SARS-CoV-2 antibody assay.
- Published in:
- 2021
- By:
- Publication type:
- journal article
First cases of Zika virus-infected US blood donors outside states with areas of active transmission.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century.
- Published in:
- Transfusion, 2013, v. 53, n. 2, p. 438, doi. 10.1111/j.1537-2995.2012.03742.x
- By:
- Publication type:
- Article
Development and application of a high-throughput microneutralization assay: lack of xenotropic murine leukemia virus-related virus and/or murine leukemia virus detection in blood donors.
- Published in:
- Transfusion, 2012, v. 52, n. 2, p. 332, doi. 10.1111/j.1537-2995.2011.03519.x
- By:
- Publication type:
- Article
The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Research Working Group: mission, progress, and plans.
- Published in:
- Transfusion, 2011, v. 51, n. 3, p. 643, doi. 10.1111/j.1537-2995.2011.03063.x
- By:
- Publication type:
- Article
Correction: Correction: A Novel Rhabdovirus Associated with Acute Hemorrhagic Fever in Central Africa.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
TARGETING THE HOST-VIRUS INTERFACE TO BLOCK SARS-CoV-2 ASSEMBLY IN AIRWAY CELLS.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 215
- By:
- Publication type:
- Article
A viral assembly inhibitor blocks SARS-CoV-2 replication in airway epithelial cells.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06130-8
- By:
- Publication type:
- Article
Standardized evaluation of Zika nucleic acid tests used in clinical settings and blood screening.
- Published in:
- PLoS Neglected Tropical Diseases, 2023, v. 16, n. 3, p. 1, doi. 10.1371/journal.pntd.0011157
- By:
- Publication type:
- Article
Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2–Infected Hamsters.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 6, p. 1702, doi. 10.1093/infdis/jiad568
- By:
- Publication type:
- Article
Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Susceptibility of Chikungunya Virus to Inactivation by Heat and Commercially and World Health Organization-Recommended Biocides.
- Published in:
- Journal of Infectious Diseases, 2018, v. 218, n. 9, p. 1507, doi. 10.1093/infdis/jiy359
- By:
- Publication type:
- Article
Susceptibility of Chikungunya Virus to Inactivation by Heat and Commercially and World Health Organization-Recommended Biocides.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20095-2
- By:
- Publication type:
- Article